Faecal reference values after Roux-en-Y gastric bypass

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28438

Enrollment

120

Registered

2014-08-27

Start date

2014-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Roux-en-Y Gastric Bypass, morbid obesity, faecal, calprotectin, elastase, alpha-1-antitrypsin.

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Patients who are 12-24 months post-RYGB.

Exclusion criteria

Exclusion criteria: - Patients who have diarrhoea at the time of faeces collection - Patients who use a PPI or NSAID, without the possibility to discontinue this medication for at least 3 days - Patients with an acute or chronic disease of stomach, intestine or pancreas which may influence the measurements made in this study. E.g.: inflammatory bowel disease, malignancy of stomach, intestine or pancreas, chronic pancreatitis, chronic bowel infection, resection of stomach or bowel other than RYGB, radiotherapy with the gut laying within the ablated area, systemic disease which influences the gastro-intestinal tract (e.g. systemic sclerosis) Not excluded are patients with e.g. cholecystectomy, bacterial gastro-enteritis or acute pancreatitis, provided that patients are fully recovered.

Design outcomes

Primary

Measure	Time frame
Determination of reference values of faecal calprotectin, elastase-1 and alpha-1-antitrypsin after RYGB	—

Contacts

Public ContactT.C.C. Boerlage

Dept. of internal medicine

thomas.boerlage@slz.nl+31 (0)20 5124945

Outcome results